scholarly article | Q13442814 |
meta-analysis | Q815382 |
P2093 | author name string | J P Hamilton | |
I H Gotlib | |||
M Siemer | |||
P2860 | cites work | Morphological sex differences and laterality in the prepubertal medial amygdala | Q48268099 |
Relationships between Amygdala Volume and Activity during Emotional Information Processing Tasks in Depressed and Never‐Depressed Individuals | Q48320972 | ||
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects | Q48388265 | ||
Amygdala core nuclei volumes are decreased in recurrent major depression | Q48425334 | ||
A functional anatomical study of unipolar depression. | Q48433687 | ||
Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression | Q48438225 | ||
Cingulate function in depression: a potential predictor of treatment response | Q48768060 | ||
A differential neural response in the human amygdala to fearful and happy facial expressions | Q48886837 | ||
Impaired judgments of sadness but not happiness following bilateral amygdala damage. | Q51003652 | ||
The amygdala and emotional memory. | Q51121525 | ||
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. | Q51941124 | ||
Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. | Q51988552 | ||
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. | Q52012874 | ||
A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. | Q52023203 | ||
Hippocampal volume reduction in major depression. | Q52172075 | ||
Volumetric Analysis of the Prefrontal Cortex, Amygdala and Hippocampus in Major Depression | Q61834282 | ||
Increased amygdala volumes in female and depressed humans. A quantitative magnetic resonance imaging study | Q73515436 | ||
Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication | Q74424004 | ||
Lower hippocampal volume in patients suffering from depression: a meta-analysis | Q79851071 | ||
Enlarged amygdala volume and reduced hippocampal volume in young women with major depression | Q81035260 | ||
Untreated Depression and Hippocampal Volume Loss | Q22306281 | ||
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
Hippocampal volume and depression: a meta-analysis of MRI studies | Q30974294 | ||
Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions | Q31160856 | ||
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders | Q31811786 | ||
Amygdala volume analysis in female twins with major depression | Q33997714 | ||
Newly generated neurons in the amygdala and adjoining cortex of adult primates. | Q34038842 | ||
Stress and depression: possible links to neuron death in the hippocampus | Q34134017 | ||
Impaired declarative memory for emotional material following bilateral amygdala damage in humans | Q34504675 | ||
Neural substrates of increased memory sensitivity for negative stimuli in major depression | Q36776052 | ||
Why stress is bad for your brain | Q36807143 | ||
Amygdala BDNF signaling is required for consolidation but not encoding of extinction | Q36925580 | ||
Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder | Q38441447 | ||
Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression | Q38448364 | ||
The effects of social environment on adult neurogenesis in the female prairie vole. | Q43947361 | ||
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. | Q44096795 | ||
Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism | Q44239950 | ||
Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala | Q44801148 | ||
Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity | Q44840035 | ||
Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. | Q45310403 | ||
Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system. | Q45989792 | ||
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. | Q46767739 | ||
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis | Q46962136 | ||
Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder | Q47335370 | ||
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. | Q47969861 | ||
Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo | Q48172704 | ||
Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. | Q48180704 | ||
Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression | Q48188547 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | major depressive disorder | Q42844 |
meta-analysis | Q815382 | ||
P304 | page(s) | 993-1000 | |
P577 | publication date | 2008-05-27 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies | |
P478 | volume | 13 |
Q40063542 | "I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and Depression |
Q33761026 | A multi-scanner study of subcortical brain volume abnormalities in schizophrenia |
Q92883417 | A neural circuit for comorbid depressive symptoms in chronic pain |
Q37015341 | A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity |
Q92603223 | A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination |
Q42955832 | A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy. |
Q34815480 | A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression |
Q52326585 | Abnormal dynamic functional connectivity of amygdalar subregions in untreated patients with first-episode major depressive disorder. |
Q34062496 | Adult-onset hypothyroidism enhances fear memory and upregulates mineralocorticoid and glucocorticoid receptors in the amygdala |
Q64235050 | Altered gray matter volume in patients with herpes zoster and postherpetic neuralgia |
Q47802190 | Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients |
Q36325111 | Amygdala functional connectivity, HPA axis genetic variation, and life stress in children and relations to anxiety and emotion regulation |
Q35188783 | Amygdala volume in late-life depression: relationship with age of onset |
Q37671722 | Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats |
Q91994660 | Analysis of genes linked to depressive-like behaviors in interleukin-18-deficient mice: Gene expression profiles in the brain |
Q92182171 | Anomalous functional connectivity of amygdala subregional networks in major depressive disorder |
Q37248756 | Anomalous gray matter structural networks in major depressive disorder. |
Q92818378 | Anxiolytic effects of polydatin through the blockade of neuroinflammation in a chronic pain mouse model |
Q31061912 | Applying a free-water correction to diffusion imaging data uncovers stress-related neural pathology in depression |
Q34370512 | Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective study. |
Q41191440 | Associations between subjective well-being and subcortical brain volumes. |
Q35180938 | Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy |
Q47794274 | Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice |
Q30465034 | Auditory memory decrements, without dissimulation, among patients with major depressive disorder |
Q35305259 | Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study |
Q58601783 | Biobehavioral threat sensitivity and amygdala volume: A twin neuroimaging study |
Q26786239 | Brain Structural Effects of Antidepressant Treatment in Major Depression |
Q33927879 | Brain anatomy of major depression II. Focus on amygdala. |
Q48246382 | Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis |
Q35616983 | Brain structural alterations associated with young women with subthreshold depression |
Q38123464 | Bridging intimate partner violence and the human brain: a literature review. |
Q33963735 | Can Functional Magnetic Resonance Imaging Improve Success Rates in CNS Drug Discovery? |
Q91046020 | Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior |
Q33841568 | Cannabis and Depression: A Twin Model Approach to Co-morbidity |
Q92696673 | Cardiac dysautonomia in depression - heart rate variability biofeedback as a potential add-on therapy |
Q35761130 | Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI. |
Q58213881 | Chronic Pain and Chronic Stress: Two Sides of the Same Coin? |
Q36161776 | Cognitive disruptions in stress-related psychiatric disorders: A role for corticotropin releasing factor (CRF). |
Q41449099 | Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms. |
Q37508045 | Cross-Sectional and Longitudinal Relationships between Depressive Symptoms and Brain Atrophy in MS Patients |
Q34000788 | Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes |
Q33747974 | Depression and Anxiety Scores Are Associated with Amygdala Volume in Cushing's Syndrome: Preliminary Study |
Q30583838 | Depression and functional cerebral imaging |
Q38096858 | Depression and temporal lobe epilepsy represent an epiphenomenon sharing similar neural networks: clinical and brain structural evidences |
Q55439706 | Depression, Olfaction, and Quality of Life: A Mutual Relationship. |
Q34248599 | Developmental risk I: depression and the developing brain |
Q38153338 | Disorders and borders: psychiatric genetics and nosology |
Q35806172 | Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy |
Q47286786 | Distinctive Neuroanatomical Substrates for Depression in Bipolar Disorder versus Major Depressive Disorder. |
Q37702535 | Do manual and voxel-based morphometry measure the same? A proof of concept study. |
Q38623862 | Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766). |
Q96022804 | ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing |
Q64235467 | Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease |
Q26779694 | Electrical Stimulation Elicits Neural Stem Cells Activation: New Perspectives in CNS Repair |
Q37456982 | Electroconvulsive Therapy-Induced Brain Structural and Functional Changes in Major Depressive Disorders: A Longitudinal Study. |
Q35790477 | Examining gray matter structures associated with individual differences in global life satisfaction in a large sample of young adults |
Q59330192 | From Gut to Brain: Alteration in Inflammation Markers in the Brain of Dextran Sodium Sulfate-induced Colitis Model Mice |
Q37464520 | Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study |
Q35760396 | Functional and structural brain correlates of risk for major depression in children with familial depression |
Q35115204 | Gender effects on amygdala morphometry in adolescent marijuana users |
Q42699257 | Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression. |
Q37406198 | Gray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization |
Q48898356 | Hippocampal shape deformation in female patients with unremitting major depressive disorder |
Q34511676 | How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy |
Q30511878 | How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure |
Q37369254 | Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants |
Q30451308 | Human amygdala volume is predicted by common DNA variation in the stathmin and serotonin transporter genes |
Q34778847 | Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression |
Q35852455 | Imaging genetics of mood disorders. |
Q35380838 | Impact of chronic hypercortisolemia on affective processing |
Q89032165 | Impaired biophysical integrity of macromolecular protein pools in the uncinate circuit in late-life depression |
Q37172637 | Impaired causal awareness and associated cortical-basal ganglia structural changes in youth psychiatric disorders. |
Q38634579 | In vivo estimation of normal amygdala volume from structural MRI scans with anatomical-based segmentation. |
Q47292589 | Increased Global Interaction Across Functional Brain Modules During Cognitive Emotion Regulation |
Q35093654 | Increased amygdalar and hippocampal volumes in young adults with social anxiety |
Q36907384 | Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk |
Q48305052 | Influence of age of onset on limbic and paralimbic structures in depression |
Q39854264 | Influence of regional cerebral blood volume on voxel-based morphometry |
Q33933405 | Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. |
Q91644471 | Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder |
Q90462310 | Integrative functional genomic analysis of human brain development and neuropsychiatric risks |
Q33579946 | Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data |
Q33846590 | Larger amygdala volume in first-degree relatives of patients with major depression |
Q64237171 | Linking personality and brain anatomy: a structural MRI approach to Reinforcement Sensitivity Theory |
Q47701936 | Low left amygdala volume is associated with a longer duration of unipolar depression |
Q89494642 | Major Depressive Disorder Associated With Reduced Cortical Thickness in Women With Temporal Lobe Epilepsy |
Q34017219 | Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. |
Q50161691 | MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder |
Q46762211 | Modeling prior information of common genetic variants improves gene discovery for neuroticism |
Q33653841 | Modulation of Brain Activity with Noninvasive Transcranial Direct Current Stimulation (tDCS): Clinical Applications and Safety Concerns |
Q60774888 | Mood Disorders |
Q90295915 | Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients |
Q35271933 | Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis |
Q89880514 | Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies |
Q38592629 | Neighborhood matters: divergent patterns of stress-induced plasticity across the brain. |
Q42689309 | Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder. |
Q35308000 | Neural basis of the association between depressive symptoms and memory deficits in nondemented subjects: resting-state fMRI study |
Q30586312 | Neural plasticity in fathers of human infants |
Q38980262 | Neural substrates of trait impulsivity, anhedonia, and irritability: Mechanisms of heterotypic comorbidity between externalizing disorders and unipolar depression |
Q45940295 | Neuroanatomical correlates of depression in Friedreich's ataxia: a voxel-based morphometry study. |
Q39117248 | Neurobiology of depression: A neurodevelopmental approach |
Q47581586 | Neurodevelopmental correlates of proneness to guilt and shame in adolescence and early adulthood. |
Q57173547 | Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression |
Q100297448 | Olfactory hallucinations in Alzheimer's disease |
Q92944827 | Outward subcortical curvature associated with sub-clinical depression symptoms in adolescents |
Q37618531 | Prenatal stress-immune programming of sex differences in comorbidity of depression and obesity/metabolic syndrome |
Q33487168 | Prognostic and diagnostic potential of the structural neuroanatomy of depression |
Q39695502 | Prospective longitudinal voxel-based morphometry study of major depressive disorder in young individuals at high familial risk. |
Q46454654 | Recent Advances in Non-invasive Brain Stimulation for Major Depressive Disorder |
Q33712231 | Reduced amygdalar and hippocampal size in adults with generalized social phobia |
Q34842199 | Reduced anterior insula, enlarged amygdala in alcoholism and associated depleted von Economo neurons |
Q37331043 | Regional brain volumes and symptom severity in body dysmorphic disorder |
Q33917424 | Relationship between cerebellar structure and emotional memory in depression |
Q57164356 | Resilience and amygdala function in older healthy and depressed adults |
Q36431730 | Robust Automated Amygdala Segmentation via Multi-Atlas Diffeomorphic Registration |
Q33523048 | Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat. |
Q36998571 | Serotonin signaling modulates the effects of familial risk for depression on cortical thickness |
Q99549654 | Shape and Volumetric Differences in the Corpus Callosum between Patients with Major Depressive Disorder and Healthy Controls |
Q36824340 | Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders |
Q47553556 | Shifting priorities: highly conserved behavioral and brain network adaptations to chronic stress across species. |
Q91903158 | Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with Major Depressive Disorder symptom severity |
Q36031052 | Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression. |
Q48983969 | Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms |
Q23747515 | Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group |
Q90556368 | Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group |
Q47370827 | Symptoms of depression in a large healthy population cohort are related to subjective memory complaints and memory performance in negative contexts. |
Q37302923 | Synaptic regulation of affective behaviors; role of BDNF |
Q48680899 | The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. |
Q37670199 | The Global ECT-MRI Research Collaboration (GEMRIC): Establishing a multi-site investigation of the neural mechanisms underlying response to electroconvulsive therapy |
Q64259676 | The Relationship Between Serum Concentration of Vitamin D, Total Intracranial Volume, and Severity of Depressive Symptoms in Patients With Major Depressive Disorder |
Q47595593 | The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder. |
Q91825121 | The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population |
Q45327931 | The effect of fermented red ginseng on depression is mediated by lipids |
Q48832594 | The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: the PREDIMED-NAVARRA randomized trial |
Q37914871 | The genetic blueprint of major depressive disorder: contributions of imaging genetics studies |
Q30363527 | The gray matter volume of the amygdala is correlated with the perception of melodic intervals: a voxel-based morphometry study. |
Q37984000 | The neurobiology of depression |
Q30399725 | The neuroscience of depression: implications for assessment and intervention |
Q28480608 | The parametric, psychological, neuropsychological, and neuroanatomical properties of self and world evaluation |
Q48039323 | The relationship of impulsivity and cortical thickness in depressed and non-depressed adolescents |
Q91825109 | The rise and fall of MRI studies in major depressive disorder |
Q36688553 | The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies |
Q34013923 | Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder |
Q39268758 | Trait positive affect is associated with hippocampal volume and change in caudate volume across adolescence |
Q40738680 | Understanding Familial Risk for Depression: A 25-Year Perspective |
Q35013716 | Variant in oxytocin receptor gene is associated with amygdala volume |
Q98196635 | Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis |
Q33822592 | Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPR. |
Q83143710 | [Depressive recurrence: cognitive alterations and neuroplasticity] |
Q38722055 | tDCS for the treatment of depression: a comprehensive review |
Q37346227 | α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability |
Search more.